OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anosmia and Ageusia in Parkinson's Disease
Arjun Tarakad, Joseph Jankovic
International review of neurobiology (2017), pp. 541-556
Closed Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Causal mapping of human brain function
Shan Siddiqi, Konrad P. Körding, Josef Parvizi, et al.
Nature reviews. Neuroscience (2022) Vol. 23, Iss. 6, pp. 361-375
Open Access | Times Cited: 221

Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium
Sonu Bhaskar, Sian Bradley, Simon Israeli‐Korn, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 85

Parkinson’s Disease and the COVID-19 Pandemic
Conor Fearon, Alfonso Fasano
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 2, pp. 431-444
Open Access | Times Cited: 83

The Promise and Challenges of Developing miRNA-Based Therapeutics for Parkinson’s Disease
Simoneide Souza Titze-de-Almeida, Cristina Soto-Sánchez, Eduardo Fernández, et al.
Cells (2020) Vol. 9, Iss. 4, pp. 841-841
Open Access | Times Cited: 63

SARS-CoV-2, an Underestimated Pathogen of the Nervous System
Shweta Jakhmola, Omkar Indari, Sayantani Chatterjee, et al.
SN Comprehensive Clinical Medicine (2020) Vol. 2, Iss. 11, pp. 2137-2146
Open Access | Times Cited: 59

α-synuclein inclusions are abundant in non-neuronal cells in the anterior olfactory nucleus of the Parkinson’s disease olfactory bulb
Taylor J. Stevenson, Helen C. Murray, Clinton Turner, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 56

Spectrum of Non-Motor Symptoms in Parkinson's Disease
Maithrayie Kumaresan, Safeera Khan
Cureus (2021)
Open Access | Times Cited: 47

Cytokine and interleukin profile in patients with headache and COVID-19: A pilot, CASE-control, study on 104 patients
Javier Trigo, David García‐Azorín, Álvaro Sierra-Mencía, et al.
The Journal of Headache and Pain (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 46

Machine learning for the detection and diagnosis of cognitive impairment in Parkinson’s Disease: A systematic review
Callum Altham, Huaizhong Zhang, Ella Pereira
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0303644-e0303644
Open Access | Times Cited: 7

“Smelling and Tasting” Parkinson's Disease: Using Senses to Improve the Knowledge of the Disease
Valentina Oppo, Marta Melis, Melania Melis, et al.
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 47

Possible Link between SARS-CoV-2 Infection and Parkinson’s Disease: The Role of Toll-Like Receptor 4
Carmela Conte
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7135-7135
Open Access | Times Cited: 33

Chemosensory Impairments and Their Impact on Nutrition in Parkinson’s Disease: A Narrative Literature Review
Sonila Alia, Elisa Andrenelli, Alice Di Paolo, et al.
Nutrients (2025) Vol. 17, Iss. 4, pp. 671-671
Open Access

The impact of indigenous microbes on Parkinson's disease
Timothy R. Sampson
Neurobiology of Disease (2019) Vol. 135, pp. 104426-104426
Open Access | Times Cited: 38

Auditory Dysfunction in Parkinson's Disease
Zahra Jafari, Bryan Kolb, Majid H. Mohajerani
Movement Disorders (2020) Vol. 35, Iss. 4, pp. 537-550
Closed Access | Times Cited: 37

The Potential Role of SARS-COV-2 in the Pathogenesis of Parkinson's Disease
Pedro Chaná‐Cuevas, Philippe Salles-Gándara, Alejandro Rojas‐Fernández, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 37

The unfolding palette of COVID-19 multisystemic syndrome and its neurological manifestations
Francisco J. Barrantes
Brain Behavior & Immunity - Health (2021) Vol. 14, pp. 100251-100251
Open Access | Times Cited: 27

Microbiota Dysbiosis in Parkinson Disease—In Search of a Biomarker
Julia Maya Nowak, Mateusz Henryk Kopczyński, Andrzej Friedman, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2057-2057
Open Access | Times Cited: 21

Advancing Parkinson’s diagnosis: seed amplification assay for α-synuclein detection in minimally invasive samples
Elizabeth Carrazana, Leonardo Montalbán-Gutiérrez, Pedro Chaná‐Cuevas, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access

Dysbiosis in Parkinson’s disease might be triggered by certain antibiotics
Gábor Ternák, Dániel Kuti, Krisztina Kovács
Medical Hypotheses (2020) Vol. 137, pp. 109564-109564
Open Access | Times Cited: 31

Parkinson’s disease and the non-motor symptoms: hyposmia, weight loss, osteosarcopenia
Marina De Rui, Eminè Meral Inelmen, Caterina Trevisan, et al.
Aging Clinical and Experimental Research (2020) Vol. 32, Iss. 7, pp. 1211-1218
Closed Access | Times Cited: 30

A Post‐COVID‐19 Parkinsonism in the Future?
A. V. Boika
Movement Disorders (2020) Vol. 35, Iss. 7, pp. 1094-1094
Open Access | Times Cited: 29

Dysgeusia
Davis C. Thomas, Deepti Chablani, Srishti Parekh, et al.
The Journal of the American Dental Association (2021) Vol. 153, Iss. 3, pp. 251-264
Open Access | Times Cited: 24

Post-COVID-19 Parkinsonism and Parkinson’s Disease Pathogenesis: The Exosomal Cargo Hypothesis
Dimitrios S. Mysiris, George D. Vavougios, Eirini Karamichali, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9739-9739
Open Access | Times Cited: 16

How Toll-like receptors influence Parkinson’s disease in the microbiome–gut–brain axis
Ziyi Zhang, Zhihui Liu, Ao Lv, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10

Page 1 - Next Page

Scroll to top